Olaf Penack

9.1k total citations
136 papers, 3.9k citations indexed

About

Olaf Penack is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Olaf Penack has authored 136 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 60 papers in Oncology and 42 papers in Immunology. Recurrent topics in Olaf Penack's work include Hematopoietic Stem Cell Transplantation (54 papers), CAR-T cell therapy research (26 papers) and Neutropenia and Cancer Infections (22 papers). Olaf Penack is often cited by papers focused on Hematopoietic Stem Cell Transplantation (54 papers), CAR-T cell therapy research (26 papers) and Neutropenia and Cancer Infections (22 papers). Olaf Penack collaborates with scholars based in Germany, United States and France. Olaf Penack's co-authors include Dieter Buchheidt, Marcel R.M. van den Brink, Ernst Holler, Georg Maschmeyer, Oliver A. Cornely, Markus Ruhnke, Martin Schmidt‐Hieber, Meinolf Karthaus, Silke Neumann and Marcus Hentrich and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Olaf Penack

131 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olaf Penack Germany	40	1.5k	1.3k	1.2k	953	944	136	3.9k
Carlos Solano Spain	35	1.3k 0.9×	1.8k 1.4×	1.6k 1.4×	840 0.9×	878 0.9×	214	4.1k
Jan Styczyński Poland	31	2.0k 1.3×	1.7k 1.3×	1.5k 1.3×	570 0.6×	979 1.0×	299	4.5k
Trudy N. Small United States	37	1.1k 0.7×	1.2k 1.0×	1.6k 1.4×	1.4k 1.5×	653 0.7×	106	3.8k
Marie von Lilienfeld‐Toal Germany	33	1.3k 0.9×	917 0.7×	1.6k 1.3×	514 0.5×	765 0.8×	110	3.9k
Christopher C. Dvorak United States	35	839 0.6×	1.1k 0.9×	1.4k 1.2×	1.0k 1.1×	699 0.7×	173	4.4k
Alexander Shimabukuro‐Vornhagen Germany	30	1.7k 1.1×	493 0.4×	529 0.5×	1.4k 1.5×	796 0.8×	100	3.8k
Sébastien Maury France	31	1.1k 0.7×	795 0.6×	1.8k 1.6×	1.1k 1.1×	706 0.7×	125	3.7k
William Krüger Germany	33	1.3k 0.8×	738 0.6×	1.4k 1.2×	409 0.4×	703 0.7×	136	3.2k
Rafael de la Cámara Spain	39	1.9k 1.3×	3.2k 2.6×	1.7k 1.5×	856 0.9×	1.6k 1.7×	154	5.7k
Lourdes Vázquez Spain	32	970 0.6×	997 0.8×	1.4k 1.2×	595 0.6×	773 0.8×	133	3.4k

Countries citing papers authored by Olaf Penack

Since Specialization

Citations

This map shows the geographic impact of Olaf Penack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Penack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Penack more than expected).

Fields of papers citing papers by Olaf Penack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf Penack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Penack. The network helps show where Olaf Penack may publish in the future.

Co-authorship network of co-authors of Olaf Penack

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf Penack. A scholar is included among the top collaborators of Olaf Penack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf Penack. Olaf Penack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2025). GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party. Leukemia. 39(6). 1503–1511.

Ortí, Guillermo, Guillaume Dachy, Charlotte Graham, et al.. (2025). Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee. Bone Marrow Transplantation. 60(6). 751–758. 2 indexed citations

Walter, Annette O., Benedikt Obermayer, David R. Busch, et al.. (2025). Prior chemotherapy deteriorates T-cell quality for CAR T-cell therapy in B-cell non-Hodgkin’s lymphoma. Journal for ImmunoTherapy of Cancer. 13(4). e010709–e010709. 6 indexed citations

Penack, Olaf, Christophe Peczynski, Daniel Wolff, et al.. (2024). Management of complications of chimeric antigen receptor T-cell therapy: a report by the European Society of Blood and Marrow Transplantation. Haematologica. 109(11). 3557–3565. 5 indexed citations

Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2024). How risky is a second allogeneic stem cell transplantation?. Leukemia. 38(8). 1799–1807. 4 indexed citations

Rejeski, Kai, Yucai Wang, Doris K. Hansen, et al.. (2024). Applying the EHA/EBMT grading for ICAHT after CAR-T: comparative incidence and association with infections and mortality. Blood Advances. 8(8). 1857–1868. 29 indexed citations

Hopff, Sina M., Annika Y. Claßen, Gesine Bug, et al.. (2024). Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study. Journal of Infection. 89(2). 106220–106220. 7 indexed citations

Albinger, Nawid, Sabine Müller, Sarah Mertlitz, et al.. (2024). Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia. Bone Marrow Transplantation. 59(4). 489–495. 21 indexed citations

Penack, Olaf, Christophe Peczynski, Zafer Gülbaş, et al.. (2024). PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation. Blood Cancer Journal. 14(1). 45–45. 13 indexed citations

10.

Rejeski, Kai, Doris K. Hansen, Yucai Wang, et al.. (2023). Applying the Novel EHA/EBMT Grading System for Icaht Following CAR-T Therapy: Comparative Incidence across Disease Entities and Association with Infections and Mortality. Blood. 142(Supplement 1). 359–359. 1 indexed citations

11.

Ayuk, Francis, Gernot Beutel, Olaf Penack, et al.. (2023). Data-driven grading of acute graft-versus-host disease. Nature Communications. 14(1). 7799–7799. 3 indexed citations

12.

Ruutu, Tapani, Christophe Peczynski, Nicolaus Kröger, et al.. (2023). The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party. Bone Marrow Transplantation. 59(2). 255–263. 3 indexed citations

13.

Perić, Zinaida, Grzegorz Basak, Christian Koenecke, et al.. (2023). Understanding the Needs and Lived Experiences of Patients With Graft-Versus-Host Disease: Real-World European Public Social Media Listening Study. JMIR Cancer. 9. e42905–e42905. 3 indexed citations

14.

Albinger, Nawid, Sarah Mertlitz, Hermann Kreyenberg, et al.. (2022). Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia. Blood Cancer Journal. 12(4). 61–61. 70 indexed citations

15.

Khaled, Samer K., Jaap Jan Boelens, Mitchell S. Cairo, et al.. (2021). Narsoplimab (OMS721), a Masp-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HSCT-TMA). Transplantation and Cellular Therapy. 27(3). S24–S26. 2 indexed citations

16.

Penack, Olaf, Christophe Peczynski, Mohamad Mohty, et al.. (2020). How much has allogeneic stem cell transplant–related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Advances. 4(24). 6283–6290. 102 indexed citations

17.

Birndt, Sebastian, Thomas Schenk, Frank M. Brunkhorst, et al.. (2020). Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. Journal of Cancer Research and Clinical Oncology. 146(4). 1065–1077. 69 indexed citations

18.

Schwarz, Constanze, Christian H. Bucher, Claudia Schlundt, et al.. (2020). Spatio-Temporal Bone Remodeling after Hematopoietic Stem Cell Transplantation. International Journal of Molecular Sciences. 22(1). 267–267. 2 indexed citations

19.

Penack, Olaf, Odette M. Smith, Amy Cunningham‐Bussel, et al.. (2009). NOD2 regulates hematopoietic cell function during graft-versus-host disease. The Journal of Experimental Medicine. 206(10). 2101–2110. 84 indexed citations

20.

Penack, Olaf, et al.. (2005). Value of Surveillance Blood Cultures in Neutropenic Patients - A Pilot Study. Japanese Journal of Infectious Diseases. 58(3). 171–173. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact